US EditionMEnera: A New OTC Biologic to Transform Women’s Reproductive Health – DIR HONGKONG
Summary by dirhongkong.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
(SeaPRwire) – FLORIDA CITY, FL, June 23, 2025 – Women seeking science-backed solutions for hormone balance and fertility support now have a new reason to hope. A cutting-edge, U.S.-based biopharmaceutical company, MEnera, announced it will launch MEnera in late 2025 – a revolutionary over-the-counter biologic designed to relieve menstrual irregularities, menopausal symptoms, PCOS, and even infertility. MEnera is the culmination of years of resea…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
